IXHL
Incannex Healthcare Ltd ADR
NASDAQ: IXHL · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$4.39
+11.99% today
Updated 2026-04-30
Market cap
$56.87M
P/E ratio
—
P/S ratio
7,764.11x
EPS (TTM)
$-22.20
Dividend yield
—
52W range
$2 – $50
Volume
2.7M
Incannex Healthcare Ltd ADR (IXHL) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-130.40%
ROA
-37.00%
Debt/equity
0.00x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | — | $-179000.00 | — | — | — |
| 2007 | — | $-900884.00 | — | — | — |
| 2008 | — | $-1.05M | — | — | — |
| 2009 | — | $-3.13M | — | — | — |
| 2010 | $22250.00 | $2.15M | 100.00% | -7,196.13% | 9,667.05% |
| 2011 | — | $-4.95M | — | — | — |
| 2012 | $67870.00 | $-3.20M | 100.00% | -5,028.13% | -4,720.73% |
| 2013 | $32611.00 | $-11.00M | 100.00% | -30,642.65% | -33,715.93% |
| 2014 | — | $-11.26M | — | — | — |
| 2015 | — | $-1.95M | — | — | — |
| 2016 | $68304.00 | $-591894.00 | 28.37% | -845.07% | -866.56% |
| 2017 | $216737.00 | $-15.90M | -83.13% | -7,429.93% | -7,336.21% |
| 2018 | $743578.00 | $-2.17M | 48.23% | -317.91% | -291.24% |
| 2019 | $825325.00 | $-1.90M | 50.60% | -236.59% | -230.67% |
| 2020 | $415627.00 | $-3.23M | 25.55% | -685.50% | -776.62% |
| 2021 | $1.90M | $-8.16M | 51.94% | -434.20% | -430.07% |
| 2022 | $540170.00 | $-10.25M | -0.81% | -1,881.67% | -1,898.02% |
| 2023 | $1.01M | $-48.81M | -8.69% | -1,345.13% | -4,814.28% |
| 2024 | $17965.00 | $-27.63M | 100.00% | -250,344.45% | -153,826.71% |
| 2025 | $86000.00 | $-46.88M | 100.00% | -27,661.63% | -54,517.44% |